Risk factor
Good trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Sino Medical Sciences Technology Inc. operates as a medical device enterprise, specializing in the research, development, manufacturing, and distribution of interventional medical devices throughout China. Its product portfolio features a range of crucial items, including drug-eluting stents, balloon catheters, coronary stents, and sophisticated transcatheter mitral valve replacement devices. Furthermore, the company maintains a clinical partnership with The National University of Ireland Galway. Established in 2007, its main operational base is situated in Tianjin, China.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of 688108.SS is 14 and suggests 28% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to